Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
165 studies found for:    Open Studies | "Thyroid Neoplasms"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia
Conditions: Thyroid Neoplasms;   Thyroid Cancer
Intervention: Procedure: Histological investigation of the SN
2 Unknown  PET Evaluation of Recurrent Differentiated Thyroid Cancer
Conditions: Thyroid Neoplasms;   Differentiated Thyroid Cancer
3 Recruiting A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Thyroid Cancer
Intervention: Drug: MLN0128
4 Recruiting An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)
Conditions: Thyroid Neoplasms;   Head and Neck Neoplasms
Interventions: Drug: C-PERT;   Drug: G-PERT
5 Recruiting Studies on Tumors of the Thyroid
Conditions: Hurthle Cell Thyroid Cancer;   Tall Cell Variant Thyroid Cancer;   Follicular Thyroid Cancer;   Thyroid Cancer;   Papillary Thyroid Cancer
6 Recruiting Nintedanib(BIBF1120) in Thyroid Cancer
Conditions: Medullary Thyroid Cancer (MTC);   Differentiated Thyroid Cancer (DTC)
Interventions: Drug: Nintedanib;   Drug: Placebo
7 Recruiting Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
Condition: Thyroid Neoplasms
Interventions: Drug: I-131;   Drug: I-125
8 Recruiting Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
Condition: Thyroid Neoplasms
Intervention: Drug: Lenvatinib
9 Recruiting Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer
Conditions: Cancer of the Thyroid;   Cancer of Thyroid;   Thyroid Cancer;   Thyroid Carcinoma
Interventions: Other: Lancet blood sampling;   Other: Standard intravenous blood sampling
10 Recruiting An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors
Condition: Thyroid Neoplasms
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Other Multikinase inhibitors
11 Recruiting A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
Conditions: Differentiated Thyroid Cancer (DTC);   Poorly Differentiated Thyroid Cancer
Intervention: Drug: Cabozantinib
12 Recruiting Institut Paoli Calmettes Thyroid Cancer Database
Condition: Thyroid Neoplasms
Intervention: Other: Data collection
13 Recruiting Thyroid Gland Removal With or Without Central Lymph Node Dissection in Treating Patients With Node Negative Thyroid Cancer
Conditions: Stage I Papillary Thyroid Cancer;   Stage II Papillary Thyroid Cancer;   Stage III Papillary Thyroid Cancer
Interventions: Procedure: thyroidectomy;   Procedure: central lymph node dissection;   Procedure: quality-of-life assessment
14 Recruiting Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
Condition: Thyroid Neoplasms
15 Unknown  Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: pemetrexed + paclitaxel
16 Recruiting Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer
Conditions: Metastatic Anaplastic Thyroid Cancer;   Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer
Intervention: Drug: Ceritinib
17 Not yet recruiting Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients
Condition: Thyroid Cancer
18 Recruiting IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
Condition: Thyroid Cancer
Intervention: Radiation: I131 1.1 GBq
19 Not yet recruiting A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)
Condition: Thyroid Cancer, Anaplastic
Intervention: Drug: Lenvatinib 24 mg
20 Recruiting Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
Condition: Thyroid Cancer
Interventions: Drug: Vemurafenib (All Groups);   Drug: Vemurafenib (Post Surgery) - Group A + C;   Other: Post Surgery - Group B

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years